A detailed history of Tang Capital Management LLC transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Tang Capital Management LLC holds 2,407,800 shares of ITOS stock, worth $17.7 Million. This represents 2.09% of its overall portfolio holdings.

Number of Shares
2,407,800
Holding current value
$17.7 Million
% of portfolio
2.09%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.09 - $17.97 $24.3 Million - $43.3 Million
2,407,800 New
2,407,800 $24.6 Million
Q4 2022

Feb 14, 2023

SELL
$17.77 - $21.6 $12.8 Million - $15.6 Million
-720,800 Reduced 76.89%
216,700 $4.23 Million
Q4 2021

Feb 14, 2022

BUY
$26.23 - $47.86 $983,625 - $1.79 Million
37,500 Added 4.17%
937,500 $43.7 Million
Q3 2021

Nov 15, 2021

BUY
$23.91 - $29.58 $16.3 Million - $20.1 Million
680,604 Added 310.22%
900,000 $24.3 Million
Q2 2021

Aug 16, 2021

BUY
$17.9 - $36.1 $3.93 Million - $7.92 Million
219,396 New
219,396 $5.63 Million

Others Institutions Holding ITOS

About iTeos Therapeutics, Inc.


  • Ticker ITOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,575,300
  • Market Cap $261M
  • Description
  • Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...
More about ITOS
Track This Portfolio

Track Tang Capital Management LLC Portfolio

Follow Tang Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tang Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tang Capital Management LLC with notifications on news.